Cantabio Pharmaceuticals Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 3/08/2017
Contact Info
  • 1250 Oakmead Pkwy
  • Sunnyvale, CA 94085

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0001550518
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2012
Employees 11 a/o Mar 31, 2013
Company Officers/Contacts
Gergely Toth CEO
Thomas Roger Sawyer COO
Simon Peace CFO
Company Directors
Simon Peace Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Thomas Roger Sawyer
Gergely Toth Nominating Committee Member
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States
Securities Counsel
Ortoli Rosenstadt LLP OTCQX Sponsor
501 Madison Avenue
14th Floor
New York, NY, 10022
United States
Investor Relations Firm
Russo Partners LLC
75 Ninth Avenue
New York, NY, 10011
United States
Company History
  • Formerly=Lion Consulting Group Inc until 10-2015
CTBO Security Details
Share Structure
Market Value1 $3,012,912 a/o May 25, 2017
Authorized Shares 250,000,000 a/o May 15, 2017
Outstanding Shares 26,805,270 a/o May 15, 2017
-Restricted 15,055,270 a/o May 15, 2017
-Unrestricted 11,750,000 a/o May 15, 2017
Held at DTC 8,750,000 a/o May 15, 2017
Float 11,750,000 a/o Jul 18, 2016
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Island Stock Transfer
Shareholders of Record 17 a/o Jul 18, 2016
Short Selling Data
Short Interest 2,807 (100%)
Mar 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security